COVAXIN added to approved list of vaccines for travel to Oman
The acceptance of COVAXIN as an approved COVID jab will significantly ease travel to Oman for Indians
Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. Image used for illustrative purpose.
By Staff Writer, Times of Oman
People in India and other countries who have been vaccinated against COVID-19 with the COVAXIN jab can now travel to Oman without the requirement for quarantine on arrival.
The development comes after the government of the Sultanate of Oman approved COVAXIN as an accepted vaccination against the coronavirus.
“All passengers from India who have received two doses of COVAXIN at least 14 days before the estimated arrival date will now be able to travel to Oman without the requirement of quarantine,” said a statement from the Embassy of India in Muscat.
“All other COVID-19 related requirements/conditions, such as pre-arrival RT-PCR tests, shall be applicable for such passengers,” added the embassy.
The acceptance of COVAXIN as an approved COVID jab will significantly ease travel to Oman for Indian and other nationals who have been administered the vaccine. Passengers who have been injected with AstraZeneca – Covishield jabs are already permitted to come to Oman without quarantine.
The Embassy of India in Muscat conveyed its gratitude to the Omani government for their cooperation in getting COVAXIN approved.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
Get Zawya's daily newsletter for insightful and exclusive Middle East perspectives on business and finance. SUBSCRIBE NOW